Founded in 2007, GenDx Biotech is committed to the development of a molecular Point-of-Care Testing (POCT) technology platform and the industrialization of comprehensive solutions for rapid gene detection across various scenarios. GenDx Biotech has been recognized as a national high-tech enterprise and is a member of the National Health Industry Enterprise Management Association.
Our team comprises molecular biology experts from the world’s PCR lab, as well as enzyme engineering and biopharmaceutical engineering experts, all of whom possess deep understanding of the fundamental technologies of PCR. We have developed a new generation of enzymatic thermostatic amplification (ERA™) technology platform, upon which we have created multiple series of rapid nucleic acid testing kits for human diagnosis, public health, food safety, and animal aquatic health.
Our goal is to develop and produce the fast and convenient nucleic acid rapid diagnostic products globally. GenDx Biotech is eager to collaborate with our global partners to make greater contributions to promoting human health.
